TF and autoimmune polyendocrinopathy: In fact, today, the long-term management of patients with APS essentially involves alternative vitamin K antagonists, such as the new oral anticoagulant agents, direct and indirect thrombin inhibitors, hydroxychloroquine, and TF inhibitors [120,121,122,123,124].